0001209191-18-021643.txt : 20180326 0001209191-18-021643.hdr.sgml : 20180326 20180326171159 ACCESSION NUMBER: 0001209191-18-021643 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180323 FILED AS OF DATE: 20180326 DATE AS OF CHANGE: 20180326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEAVER GREGORY L CENTRAL INDEX KEY: 0001251779 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31326 FILM NUMBER: 18713459 MAIL ADDRESS: STREET 1: 185 BERRY STREET STREET 2: SUITE 6504 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eloxx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001035354 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 841368850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (858) 909-0749 MAIL ADDRESS: STREET 1: 950 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Sevion Therapeutics, Inc. DATE OF NAME CHANGE: 20140930 FORMER COMPANY: FORMER CONFORMED NAME: SENESCO TECHNOLOGIES INC DATE OF NAME CHANGE: 19991006 FORMER COMPANY: FORMER CONFORMED NAME: NAVA LEISURE USA INC DATE OF NAME CHANGE: 19970310 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-23 0 0001035354 Eloxx Pharmaceuticals, Inc. ELOX 0001251779 WEAVER GREGORY L C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET, 4TH FLOOR NORTH WALTHAM MA 02451 0 1 0 0 Chief Financial Officer Common Stock 2018-03-23 4 P 0 4500 8.56 A 4500 D /s/ Gregory Weaver 2018-03-26